On Thursday’s episode of Mad Money, host Jim Cramer turned his focus to large-cap stocks that surged by $10 or more in a single day.

“You always wish you had a stock that went up 10 bucks in a day, and today we had a bunch of them. It’s a sign that there is a gigantic change afoot, possibly the beginning of something that can make you a lot of money.”

READ ALSO: Jim Cramer Weighed In on These 16 Stocks and 17 Stocks on Jim Cramer’s Radar.

Cramer laid out what he calls the “holy quadruple” for a stock to pull off such a move: it must beat both earnings and revenue estimates and raise guidance on both as well, and all four must be strong. He mentioned that the company should have “good news on the tariff front”. He also pointed to encouraging developments in currency, noting that with the dollar weakening, American companies could regain an edge after years of foreign currency manipulation.

Beyond external factors, Cramer stressed that companies must deal with internal weaknesses, whether it is fading products, copycats, or leapfrogging tech, the business has to adapt. He added that any problems from the prior quarter must be fixed. He also emphasized the importance of margin growth and said he is especially impressed by companies that make bold, eye-catching projections.

“Finally, we want to know that the company has figured out that we want growth, high growth, and then more growth, and we don’t want so-called safety… With earnings season in full swing, it’s time to check your stocks to see if they can fit the formula I just gave you… That checklist is actually pretty good. Took me all day.”

Our Methodology

For this article, we compiled a list of 14 stocks that were discussed by Jim Cramer during the episodes of Mad Money aired on July 17. We listed the stocks in the order that Cramer mentioned them. We also provided hedge fund sentiment for each stock as of the first quarter of 2025, which was taken from Insider Monkey’s database of 1,000 hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Jim Cramer Shed Light on These 14 Stocks

14. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 119

Eli Lilly and Company (NYSE:LLY) is one of the stocks that Jim Cramer shed light on. While Cramer still backed the company, he did express uncertainty about its future as he stated:

“What I’m thinking, as someone who owns Eli Lilly for the Charitable Trust and who wishes I owned PepsiCo, is that there might be a short-term peak in the use of these drugs (GLP-1s). The Achilles heel of these drugs is that they’re too effective. At some point, you lose enough weight, and you might think you can stop taking them… Whatever the case, if Eli Lilly is going to break out from this level, it needs breakthroughs in new areas, heart, brain, that it just doesn’t have right now, or there has to be some new data that shows something else positive that the GLP-1 drugs can do.

And of course, it’s got to start coming in pill form because people are tired of taking needles. I still like the stock of Eli Lilly. We have a huge gain in this one for the Charitable Trust. We’re going to hang on to it for now. But PepsiCo’s breakout, a lack of Lilly’s breakthroughs, and a reminder that at one point we were thinking of buying the airlines because of these GLP-1 drugs means that I no longer feel as certain about Lilly’s future without science that says these drugs do a lot more than just control diabetes and make you lose some weight.”

Eli Lilly (NYSE:LLY) is engaged in the research, development, and sale of pharmaceutical products, including therapies for diabetes, cancer, autoimmune disorders, pain, and migraines.

13. Cameco Corporation (NYSE:CCJ)

Number of Hedge Fund Holders: 58

Cameco Corporation (NYSE:CCJ) is one of the stocks that Jim Cramer shed light on. A caller asked about the company during the lightning round, and Cramer stated:

“I like CCJ. It’s one of the stocks, it’s one of those, along with Oklo and the small form reactors too. I just think that this is a winner. What am I going to say? I am pro-nuke, and I think people should be in them.”

Cameco (NYSE:CCJ) supplies uranium for electricity generation through activities such as mining, refining, and conversion. Additionally, the company provides nuclear technology, equipment, and services to commercial utilities and government agencies. Meridian Contrarian Fund stated the following regarding Cameco Corporation (NYSE:CCJ) in its Q1 2025 investor letter:

“Cameco Corporation (NYSE:CCJ) is a global leader in the mining, fabrication, and refinement of uranium products for nuclear power plants around the world. We view the company as a best-in-class operator with world-leading reserves and a low-cost profile. Cameco had been out of favor for many years following the 2011 Fukushima nuclear disaster, but became increasingly attractive as global uranium production declined below demand. We invested in 2020, believing uranium prices would recover and that there was upside optionality in the potentially resurgent interest in nuclear power. While the stock performed strongly in 2024, it weakened in the quarter as uranium stocks had become tied to the power-hungry AI data center trade. As such, the stock’s volatility far exceeded its fundamentals. Our position was unchanged during the quarter as we continue to base our investment on a 5- to 10-year investment thesis.”